Got $20? These 3 Healthcare Stocks Could Be Bargain Buys for 2022 and Beyond

·6 min read
Got $20? These 3 Healthcare Stocks Could Be Bargain Buys for 2022 and Beyond

On top of those pluses, these three companies all have a history of offering above-average dividends, making them solid long-term value bargains. Takeda is a Japanese biopharmaceutical company that focuses on gastroenterology, oncology, neuroscience, and rare diseases. The company's stock is up more than 9% this year, currently trading at just shy of $15.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting